Mitsubishi Chemical Group (4188) Q3 2025 earnings summary

Executive summary

• Q3 FY2024 saw stable business conditions with regional and sectoral demand variations; display and semiconductor-related sales were strong, while automotive and food sectors lagged.

• Group-wide cost reduction efforts reached 87% of the four-year target; sales revenue rose 3% to ¥3,331.5 billion and core operating income increased 34% to ¥247.2 billion year-on-year.

• Net income attributable to owners fell 43% year-on-year to ¥59.4 billion due to business structure reform expenses, but exceeded the full-year forecast.

• Full-year forecasts for revenue, net income, and dividends remain unchanged despite Q4 headwinds.

Financial highlights

• Sales revenue: ¥3,331.5 billion, up 3% year-on-year, aided by a weaker yen and higher selling prices.

• Core operating income: ¥247.2 billion, up 34% year-on-year, reaching 85% of the full-year forecast.

• Net income attributable to owners: ¥59.4 billion, down 43% year-on-year, but above the revised full-year forecast.

• Special items: Net loss of ¥57.7 billion, including a ¥16.8 billion impairment from the discontinued US MMA plant project.

• Operating income for the nine months was ¥189.5 billion, down 11% year-on-year; income before taxes was ¥161.5 billion, down 16%.

Outlook and guidance

• Q4 expected to be weaker across most segments due to seasonal factors, cost concentration, and softer demand.

• Full-year forecasts maintained: core operating income ¥290.0 billion, net income ¥52.0 billion, dividend ¥32 per share.

• Recovery in carbon products and composites targeted for FY25; full benefit from pricing policy expected over the next 12 months.

• Ongoing focus on portfolio transformation and profit improvement under the Medium-term Management Plan 2029.